Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AbbVie Inc.

AbbVie Inc. (ABBV) Stock Overview

Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.

ABBV●NYSE
HealthcareDrug Manufacturers - General
$261.70
$4.58(1.78%)
U.S. Market opens in 6h 54m

AbbVie Inc. (ABBV)

Meyka AI Score

Z

Key Financials

Market Cap462.4B
P/E Ratio72.34
EPS (TTM)$10.19
ROE-1.36%
Fundamental Analysis

AI Price Forecasts

1 Month$278.01
3 Months$258.77
1 Year Target$238.93

ABBV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of AbbVie Inc. (NYSE: ABBV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AbbVie Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABBV on the NYSE shows an RSI of 56.91, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $238.93 for the NYSE listing.

Key metrics behind AbbVie Inc.'s NYSE-traded stock include a P/E ratio of 72.34 and a market capitalization of 462.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABBV on the NYSE.

Price Performance (NYSE: ABBV)

1-Day Change
1.78%
5-Day Change
5.64%
1-Month Change
4.91%
3-Month Change
14.92%
6-Month Change
19.13%
Year-to-Date (YTD) Change
14.53%
1-Year Change
20.26%
3-Year Change
70.33%
5-Year Change
145.77%
All-Time (Max) Change
647.71%

Contact Information

https://www.abbvie.com
847 932 7900
1 North Waukegan Road, North Chicago, IL, 60064-6400

Company Facts

570,000 Employees
IPO DateJan 2, 2013
CountryUS
Actively Trading

Frequently Asked Questions